Tài liệu, văn bản bạn tìm kiếm
Multidomain transmembrane, BRCA2 mutations characterized, Clonogenic capacity, Pre-diabetes appears, Cathepsin K, Cysteine cathepsins, Ongoing healthcare reform, Benign obstetrician, Fibroglandular breast tissue, Neoadjuvant degarelix, Apalutamide followed, Placebocontrolled trial, Tumour genomic profiling, Germline sequencing, Oxygenated solvents, Localized gastric cancer, Cancer bioinformatics, In silico modeling, Alternative animal experimentation, Investigator questionnaire, Peptidyl arginine deiminase, BB-cl-Amidine, Thoracic malignant tumor, Locally advanced disease, Tumor neoantigens, Population-level distribution, Putative immunogenicity, Cancer neoepitopes, Revision rate, Recurrent gastric cancer, Oral fluoropyrimidine, B-cell lymphoma 2, DNA fragmentation factor 40, DNA fragmentation factor 45, Endometrial cancers, Activated CD4+, Adjuvant platinum-based chemotherapy, Histone H3, Remarkable antitumor activities, Potential antitumor drug, Bortezomib prevents cytarabine, NF-κB activity, High-dose cytarabine, Small renal tumor remains, Zymogen granule protein 16, Pathogenic mutations, Mesothelioma stem cell, RN5-EOS-Puro2 cells, Cancer cell repopulation, Recombinant TRAIL, Caspase-dependent, Various proteasome inhibitors, ZBP-89, Kruppel family, Comparative transcriptome analyses, Zinc binding protein 89, Specificity protein, Medical expenses, Per capita disposable, BCMO1 polymorphisms, Germline genomic sequencing, Synchronous cancer, Chemotherapy scheme modifications, Melanoma brain metastasis, Tumor regression, Malignant epithelioid mesothelioma, Standard chemotherapy, Health economic modeling, Adenoma detection rate, Proximal serrated polyp detection rate, Subungual glomus tumor, Embryonic Liver Fodrin, Finger infection, Rare benign neoplasm, Tissue heterogeneity, Non-completion, Survival rates, Fast track endoscopy, Dose reduction, Metastatic colon cancer, Bone morphogenetic protein 1, Cell mobility, Anti-HER2 therapy, Multi-gene signature, Common gene, Common function, Septin 7, Calcium-binding protein calretinin, Butyrate-responsive elements, Cancer-initiating cells, Major histocompatibility complex-I, Cytotoxic T lymphocytes, Transformed phenotype, Multiple variables, Colony-formation, Transcription factor PAX6, Anaplastic astrocytic glioma, Iodide uptake, Thyroid cells, Harrell’s C-index, Occult blood, Fecal immunochemical test, Female breast cancer, Aden Cancer Registry, Hodgkin diseases, Nonhodgkin lymphoma, E-selectin ligands, Sialyl-Lewis X, Sialyl-Lewis a, Extra-capsular growth, Low-risk prostate cancer, Computerized tomography, Adverse pathologic features, Nongestational choriocarcinoma, Spontaneous renal hemorrhage, Heterogeneous patient group, Dickkopf-1, Serrated polyps, Sessile serrated polyps, Cut value, Delay seeking healthcare, NF-κB and CREB, Advanced adenomas, ß-catenin pathway, Tumor area, Therapeutic genes, Laterally spreading tumour, Survival analysiss, Gene expression pattern analysis, High-grade intraepithelial neoplasia, Cancer diagnostics, Total number of lymph nodes, Lymph node ratio, Left colon cancer, Patient education websites, Testicular malignancy, Primary cardiac mycofibrosarcoma, Mean survival time, Breast cancer etiology, CD8+ tumor-infiltrating lymphocytes, Metabolomic profiles, T cell activation, Aerobic conditions, Normal cells metabolize energy, Pancreatic exocrine insufficiency, Unresectable pancreatic cancer, Pancreatic enzyme replacement therapy, Glutamate oxaloacetate transaminase 1, KRAS mutated cancer cells, Immunologically silent neoplasm, Integrin beta 3, TNC-associated integrin β3, Immunomodulatory agent, Establish pharmacokinetic parameters, Multinucleated phenotype, Nucleoporin Nup88, Nuclear pore complexes, Non-V600 BRAF mutation, PDX model, Orthotropic xenografts, Achieve increased therapeutic, Breast cancer model, Single selumetinib treatment, Ceramide transport, Ceramide synthesis, Ceramide distribution, Lipid transport, NF-κB upstream regulator, Lung adenocarcinoma cells, CRC tumors, Renal epithelioid angiomyolipoma, TSC2 mutation, Multi-level features extraction, mTOR pathway activation, Features fusion, Critical negative regulators, Features selection, H3K9 methyltransferase, T-lymphom invasion, Angiopoietin-like 4, Checkpoint blockade, Intracranial metastases, Immunotherapeutic treatment, Microwell-mesh platform, GSK-3 inhibitor, GSK-3 alpha, GSK-3 beta, NB cell lines, Base excision repair, AntiPD1 immunother, AntiMEK inhibitors, Histopathologic regression, Blood DNA, Epigenetic signature, Osteosarcoma patients according, Standard treatment, Unique clinical, Prognostic features according, HPV related cancer, Child health clinic, Multivariable logistic regressions model, Implantable biodegradable balloon, Rectal spacer, Ovarian cancer survival, Prediction of metastasis, Cancer antigen 125, Ca-125 marker, Mesenchymal-epithelial transition factor, Radiation resistance, Downstream pathways played, Autophagy-related, Minimal invasive surgery, Forkhead box protein C2, Aggressive phenotypes, Cystathionine-β-synthase, Cystathionine γ-lyase, ß-blocker, 3-Mercaptopyruvate sulfurtransfera, Repurposed drugs, NF-kappaB, IKK-epsilon, Non-canonical signaling, Dose Hypofractionation, Paired rectal cancer cell lines, Inflammatory response biomarker, Emerging inflammatory response biomarkers, Actinomycin D, β-hCG, Vaginal neoplasm, Primary malignant melanoma, Oral anti-fungal agent, Canine inflammatory mammary cancer, Mice model, Rembrandt dataset, Gene-amplified, Apatinib treatment, Non-comparative phase II, Relapsed angiosarcoma, Glycolytic pathway, Combination strategies, Novel therapeutic approaches, Prevalent cancers, Noncytopathic DNA viruses, Liver endothelial cells, Pre-existing vasculature, Biological mechanisms, 37 kDa/67 kDa laminin receptor, Cancer remains, Haemophagocytic lymphohistiocytosis, Acute monocytic leukemia, Prompt diagnosis, Malignancy-associated HLH, Combined androgen blockade, Gonadotropin-releasing hormone receptor antagonist, First-in-human trial, Rare tumors occurring predominantly, Human phase I, Proteasomal degradation, Subsequent care, Tumor suppressor role, STAT1 ubiquitination, Tumor subtypes, PSCA expression, Tumor features, Prostate Stem Cell Antigen, Hyperprogressive disease, Peritoneal dissemination, Pediatric malignancies, Primary cell lines, Mediastinal lymph, Switch maintenance therapy, Propensity score matching study, Human pulmonary malignancies, Versus transarterial chemoembolization, SRY-box containing gene 30, Cytoplasmic IgD, RUNX1 overlapping RNA, Plasmablastic lymphoma, Prognosis remains extremely poor, Cytostatic drugs, Thalidomide plus, Drug eluting beads, Chromosomal imbalance analysis, Cancer stem cells markers, Enhanced tumorigenicity, N-acetylglucosamine, Diffusely infiltrating astrocytomas originate, Astrocytic glial cells, HIF-alpha, Tumour micro-environment, BRAF melanoma, ATP-binding cassette transporter 5, Including DNA, RecQ DNA helicase family, RECQL mutations, Tumor-associated fibroblasts, TGF-beta, Uterine serous carcinoma, Type II endometrial cancer, Extraceullular matrix, Double-strand break repair, Nucleotide excision repair pathways, Heparan sulfate, Mitotic catastrophe, Threonine kinase-like, Antitumor mechanism, Methyl capture sequencing, TP53 signaling pathway, Tracheal perforation, Locally advanced gastric cancer, Curative resection rate, Preoperative controlling nutritional, Trinidad and Tobago, Cancer in populations of Indian ancestry, Hippo tumor suppressor pathway, YAP mediates, HSP-Clusts, Chemotherapy related cardiotoxicity, Eribulin mesylate, 3-O-acetyloleanolic acid, Sentinel lymph node metastasis, Trans-arterial radio-embolization, Tumoral macrovascular, Circulating miRNAs, AB0 blood groups, Rhesus factor, Change-points, Mole pregnancy, Invasive mole, Uterine perforation, Ficolin-3, Familial cancer predisposition, Genetic cancer susceptibility, Costs and cost analysis, Related risk factors, Endometrial stromal sarcoma, Translocated endometrial stromal sarcoma, NLRP3 inflammasome, S-1 plus oxaliplatin, Multimodality therapy including surgery, Treatment-related death, Mock vector-transfected cells, Genetic rearrangement, Harboring genetic rearrangements, Guide treatment strategy, Weekly nab-paclitaxel plus gemcitabine, CSF3R mutation, Prognosis factors, Extramammary Paget disease, Anatomic sites, Aberrant hyperactivation, Unopposed estrogen, Non-EMPD related cancers, Therapeutic schemes, Hierarchical ordinal regression, Multi-level drug response, Acute promyelocytic leukaemia, Credit value adjustment, Oral cavity tumor, Wrong way risk, Colonic adenocarcinoma of the tongue, Right way risk, Colonic adenocarcinoma subtype., Least square Monte Carlo, Default time approach (DTA), Default probability approach, Gene rbcL, Genus Stephania (Menispermaceae), Chloroplast rbcL gene, Relationship between species, Asia Pacific ocean, Hereditary characteristics, Protoperidinium anomaloplaxum (Peridiniales, S339L mutation, Dinophyceae), Maple syrup urine disease in Vietnam, Vietnamese waters, New record for ASIA-Pacific, Osteoblast MC3T3-E1, Osteogenesis activity, Free-living soil nematodes, East sea, Osteogenesis activity of fractions extracted, Blood type A, Natural conservation area, Gulf of tonkin, Store insect pests, Asian Elephant, Single chain antibody, Marine fishes of Vietnam, Sitophilus zeamais (Motschulsky), Pumat National Park, Parkellus menzeli male in Vietnam, Updated list of Monogenoidea, Maize weevil Sitophilus zeamais, Chain antibody recognizing blood type a antigen, Redescription of Parkellus menzeli male, Electron arrangements, Form molecules, Quá trình tính toán phân tích